RecruitingPhase 4NCT06291363

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

Impact of Continuous Intraoperative Administration of Esmolol on Nociception Level-guided Control of Nociception. The EsmoNOL Randomized Controlled Trial

Sponsor

Ciusss de L'Est de l'Île de Montréal

Enrollment

64 participants

Start Date

Apr 16, 2024

Study Type

INTERVENTIONAL

Conditions

Anesthesia Nociceptive Pain Opioid Use, Unspecified

Summary

This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Esmolol Hydrochloride and a drug called Saline for people with anesthesia, nociceptive pain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.